Logo
    Search

    Podcast Summary

    • Exploring Less Common Approaches to Insomnia TreatmentCME programs, like psychiatrypodcast.com, offer convenient access to essential knowledge, reducing burnout and increasing job satisfaction. This episode focuses on insomnia treatment, featuring experts discussing less common approaches and valuable research on mental health and sleep.

      Continuing medical education (CME) can help reduce burnout and increase job satisfaction for healthcare professionals. The convenience of joining a CME membership, like the one offered through psychiatrypodcast.com, can save time and provide easy access to essential knowledge. In this episode, the discussion revolves around treating insomnia, with a focus on less common approaches like managing screens before bedtime and the use of various sleep medications. The podcast also features guest speakers, doctors Tomatsu and Krishnan, who bring valuable insights from their research on the biopsychosocial connection between mental health and sleep, as well as trauma therapy for the LGBTQ community. The comprehensive handout they've prepared is an impressive resource for healthcare professionals. The episode addresses a multitude of questions from listeners, making it a valuable learning experience. Overall, the goal is to provide practical, translatable knowledge that can be directly applied to clinical practice.

    • Understanding the Different Phases of InsomniaInsomnia can be caused by various factors and is categorized into three phases: initial, middle, and terminal. Identifying the underlying cause is essential before prescribing medication, and CBT-I is the gold standard recommendation, but it's often not the first choice due to its time-consuming nature and cost.

      Insomnia can be caused by a variety of factors, including psychiatric disorders, medical illnesses, and even viruses like COVID-19. Sleep scientists describe insomnia in three phases: initial, middle, and terminal. Initial insomnia is difficulty going to sleep, middle insomnia is waking up during the night, and terminal insomnia is waking up too early. When treating insomnia, it's important for healthcare professionals to identify the underlying cause before prescribing medication. The gold standard recommendation from the American Academy of Sleep Medicine is Cognitive Behavioral Therapy for Insomnia (CBT-I), but it's often not the first choice due to its time-intensive nature and cost. While medication can help a person fall asleep, it may not address the underlying cause of insomnia. Insomnia can be a symptom of other conditions, such as anxiety or depression, or a result of medical issues, so it's crucial to consider these possibilities before prescribing a treatment.

    • Bright light before bedtime disrupts sleepAvoid bright light exposure for a few hours before bedtime to improve sleep quality, especially from screens emitting blue-green light.

      Exposure to bright light, especially from screens, close to bedtime can disrupt your sleep by suppressing melatonin production. This can cause difficulty falling asleep and delaying the onset of your sleep-wake cycle. Many people engage in activities like drinking caffeine, using bright screens for late-night reading or work, and irregular sleep patterns due to shift work, which can also contribute to insomnia. Humans are most sensitive to light in the blue-green part of the spectrum, which is emitted by many screens, making it even more disruptive to sleep. To improve sleep quality, it's recommended to avoid bright light exposure for at least a few hours before bedtime. The optimal time may vary, but stopping exposure around 8 PM is a good starting point for most people. Additionally, the quality of blue light blocking glasses can be inconsistent, so it might be more effective to simply avoid bright screens close to bedtime.

    • Improving Sleep Quality with Sleep HygienePersonalize sleep hygiene for better sleep by avoiding work projects, arguments, and screens before bed. Try calming alternatives like white noise or specific TV shows. In the inpatient setting, avoid exercise before bedtime. Ensure a dark and dim sleep environment and set timers for devices.

      Establishing healthy sleep habits, or sleep hygiene, is crucial for improving sleep quality. Sleep associations, such as using a phone or watching TV before bed, can be hard to break due to their familiarity. Instead, consider calming alternatives like background white noise. Eliminating work projects or arguments in bed are also recommended. Interestingly, some people may find that certain sleep associations, like watching specific TV shows, can actually help them fall asleep. In the inpatient setting, avoiding exercise before bedtime is important, as it increases sympathetic activity and can keep you awake. For those who need to exercise, aerobic exercise is beneficial but should not be done right before bed. Additionally, ensuring a dark and dim sleep environment, and setting a timer for TV shows or other devices, can help minimize disruptive elements. Overall, personalizing sleep hygiene to individual needs and preferences can lead to better sleep.

    • Minimizing medication disruptions to improve sleep in hospitalsConsider alternative methods for managing patients' conditions and use sedatives or anxiolytics for the shortest duration possible to minimize sleep disruptions and potential increased mortality risk.

      While pharmaceutical options are often necessary in healthcare, there are ways to minimize their use, particularly when it comes to medications that disrupt sleep. These disruptions can occur due to frequent vital checks in the middle of the night or medications that are given at inconvenient times. Hospitals can improve the sleep environment by adjusting lighting and noise levels, but this may not be feasible in all units, such as ICUs. Chronic use of sedatives or anxiolytics, including Benzodiazepines and the Z drugs, has been associated with increased mortality rates. Therefore, it's essential to consider alternative methods for managing patients' conditions and use these medications for the shortest duration possible. A large UK study found that people taking sedatives or anxiolytics for extended periods had a higher all-cause mortality rate than those not taking these medications. While these patients may have had other health issues, the study suggests that the drugs themselves may contribute to the increased risk.

    • Comparing Sedatives and Anxiolytics for Insomnia: A Large-Scale StudyThe study found that Benzodiazepines, while effective for short-term insomnia treatment, have high misuse rates, particularly among younger adults. CBT-I is more effective in the long term but is underutilized. Providers can consider short-term use of sedatives for transient insomnia and effective interventions for circadian disturbances.

      A large-scale study was conducted to compare the effects of sedatives and anxiolytics on insomnia, as smaller studies had produced mixed results due to varying illnesses and drug lengths. The study found that 12.6% of adults reported past-year Benzodiazepine use, with misuse accounting for nearly 20%. The highest misuse was in the younger population, while the highest number of prescriptions was in adults over 50. However, Benzodiazepines are only effective for short-term insomnia treatment, as individuals become tolerant to their sedative effects within weeks. Instead, Cognitive Behavioral Therapy for Insomnia (CBT-I) is more effective in the long term, but it's challenging to get patients into this treatment. As providers, short-term use of sedatives, particularly the z drugs, can be helpful for those with transient or acute insomnia. Additionally, there are effective interventions for treating circadian disturbances.

    • Melatonin and its analogs for treating circadian disturbancesMelatonin and its synthetic forms can help manage insomnia from shift work or jet lag. Optimal dosage is 3-5mg, taken an hour before bedtime. Ramelteon, specifically, improves sleep onset and early stage sleep, and may be covered by insurance for certain conditions.

      Melatonin and its synthetic analogs, such as Ramelteon and Tasamelteon, can be effective treatments for circadian disturbances, including insomnia caused by shift work or jet lag. The optimal dose for most adults is between 3-5 milligrams, taken about an hour before bedtime. While higher doses can make the user drowsy, they may also cause impairment of alertness and cognition the following day. Melatonin's short half-life means that it goes away quickly when taken as a pill, unlike the natural melatonin produced by the pineal gland. Ramelteon, specifically, has a poor bioavailability and primarily helps with sleep onset and early stage sleep. Its use may be covered by insurance for certain conditions, such as phase advance of the sleep-wake cycle, which can help older adults adjust to social obligations. Overall, these medications can be useful for managing circadian disturbances, but it's important to consult a healthcare professional for dosage and specific application.

    • Benzodiazepines impact on sleep and dementiaBenzodiazepines, while helping sleep initiation, can cause daytime impairment depending on their half-life. Long-term use increases dementia risk, but the calming effect might reduce it. Gradual tapering is crucial to avoid relapse or withdrawal symptoms.

      While melatonin and its analogs have minimal effect on sleep regardless of the time of day, benzodiazepines, which are commonly used for sleep and anxiety, can have significant daytime impairment depending on their half-life. Chronic use of benzodiazepines is associated with an increased risk of dementia, although it's unclear if the drug is the cause. The calming effect of benzodiazepines may reduce the risk of dementia, but the increased risk of depression and mortality might offset this benefit. If tapering a patient off benzodiazepines, it's crucial to do so very gradually due to the risk of relapse or withdrawal symptoms. In elderly patients, it's best to avoid chronic benzodiazepine use for sleep.

    • Gradual tapering off Benzodiazepines is essentialSlowly decrease Benzodiazepine dosages over 6-12 months to prevent relapses or catatonia. Use antihistamines like hydroxyzine as alternatives for sedatives and consider trazodone for sleep, but recognize its limited effectiveness compared to placebo.

      When it comes to tapering patients off Benzodiazepines, a slow and gradual approach is crucial to prevent relapses or the development of catatonia. While some physicians may be in a hurry to reduce dosages, the brain is more tolerant of gradual change. A decrease in dosage should ideally be spread over 6 months to 12 months. Benzodiazepines are best used as short-term rescue medications, recognizing that some clinical circumstances may require long-term use. They can be compared to high-potency steroids, excellent for rescue but miserable long-term medications. For sedatives, antihistamines like hydroxyzine are a preferred option due to their minimal side effects. Trazodone, while commonly used for sleep, may not be as effective as placebo in helping patients fall asleep faster or return to sleep quicker. Its popularity may be due to the historical concern of tolerance and dependency with Benzodiazepines, leading to an increase in trazodone prescriptions during that time.

    • Considering the Risks and Benefits of Sedatives for InsomniaAntihistamines like hydroxyzine and trazodone can help with insomnia but come with risks and considerations. Trazodone can worsen bipolar disorder and cause disrupted sleep, while hydroxyzine lacks anticholinergic side effects. Mirtazapine and magnesium also have potential benefits and risks.

      While antihistamines like hydroxyzine and trazodone can be effective sedatives, they come with risks and considerations. Trazodone, being an antidepressant, can worsen conditions like bipolar disorder if given to someone experiencing hypomania or mania. Additionally, trazodone can cause sedation with a second dip, leading to disrupted sleep. Hydroxyzine, on the other hand, lacks the undesirable side effects of anticholinergic drugs like diphenhydramine. Mirtazapine, another option, acts primarily as an antihistamine at low doses and can be effective for some patients, but carries the risk of discontinuation syndromes. Magnesium, which some people report helps with insomnia, has a theoretical mechanism for calming effects but lacks substantial evidence from well-controlled studies. It's important for healthcare professionals to carefully consider the risks and benefits of each option when prescribing sedatives for their patients.

    • Be Aware of Sleep Medications' Side EffectsAntihistamine OTC meds can impair memory and cause side effects. Herbal sedatives like Valerian have inconsistent quality. Prescription meds like Seroquel have concerning side effects. For sleep apnea, consider quieter machines, surgical revisions, or weight loss. Z drugs and Benzodiazepines are not effective or dangerous respectively.

      When it comes to over-the-counter sleeping medications, people should be cautious as many contain antihistamines, like Diphenhydramine (Benadryl), which have anticholinergic side effects leading to memory impairment, blurred vision, dry mouth, constipation, and urinary retention. Valerian, a commonly used herbal sedative, has sedative effects but the quality of products can be inconsistent. Prescription medications like Seroquel, which is sometimes used off-label for sleep due to its antihistamine properties, can have concerning side effects such as hypotension. For those with sleep apnea not responding to CPAP machines, options include trying quieter machines, surgical revisions, and weight loss. However, z drugs like Azopetine and zolpidem have not been found to be effective for sleep apnea and Benzodiazepines are dangerous due to the risk of causing both obstructive and central apnea.

    • Maintaining Comfort with CPAP MachinesAddressing discomfort and noise with CPAP machines is essential for effective use. Melatonin can help patients fall asleep, while eszopiclone is often used for acute insomnia in bipolar patients, but individual responses should guide dosage.

      Ensuring a good fit and comfort level with Continuous Positive Airway Pressure (CPAP) machines is crucial for effective use. These machines help maintain airways during sleep, but their discomfort and noise can lead to resistance. It's essential to address any issues promptly, such as adjusting the mask or using earplugs for noise reduction. Melatonin is a safe option for patients to help them fall asleep while wearing CPAP machines. For acute treatment of insomnia in bipolar patients, eszopiclone is often the first choice, with doses sometimes increased during manic episodes to maintain sleep. However, it's important to note that these higher doses are not necessary during non-manic periods. As always, individual patient needs and responses should guide treatment decisions.

    • Combining Antidepressants and Sleep Aids for InsomniaFor terminal insomnia, treating underlying depression is key. Antidepressant fluoxetine with esopiclone is effective in reducing depressive symptoms and improving sleep quality.

      While zopiclone and zolpidem are effective in treating insomnia, they come with potential side effects such as dry mouth, unpleasant taste, and in higher doses, dissociative episodes. Zolpidem is particularly prone to causing dissociative mental states when combined with alcohol or cannabis. For terminal insomnia, treating the underlying depression is the primary approach, and sedatives with short half-lives like zopiclone and zolpidem may not be effective. A study from 2006 found that combining fluoxetine and esopiclone led to greater reductions in depressive symptoms and improvements in sleep quality for patients with major depressive disorder and persistent insomnia. Esopiclone has been the most effective z drug in this context. It's important to note that alcohol and cannabis use can significantly increase the risk of dissociative states when taking these medications.

    • Considering Factors Beyond Medication for InsomniaWhen treating insomnia, consider factors beyond medication, such as patient's unique needs, lifestyle, and underlying causes like trauma. Esopiclone is a better option for terminal insomnia, while sedative drugs with shortest half-lives are recommended for vertigo. Always ask questions and consider lifestyle factors for effective treatment.

      When dealing with insomnia, it's crucial to consider various factors beyond just prescribing medication. Zolpidem and zalopline may not be effective for terminal insomnia due to their short half-lives. Esopiclone is a better option. When treating dizziness, it's essential to avoid drugs with alpha adrenergic antagonist properties if the patient has orthostatic hypotension. For vertigo, sedative drugs generally don't worsen symptoms, but some patients may experience exquisite sensitiveness to mild ataxia. In such cases, using chronobiologic drugs like melatonin or sedative drugs with the shortest half-lives, such as xalepol, is recommended. Remember, every patient is unique, and lifestyle factors like exercise and personal preferences should also be considered. Always ask questions before choosing an intervention and keep in mind that not everyone responds the same way to treatments. Additionally, trauma can contribute to insomnia, and addressing it may be necessary for effective treatment.

    • Emphasizing the importance of addressing trauma in mental healthContinuing education through CME and mentorship plays a crucial role in understanding and effectively addressing the underlying trauma in mental health issues.

      Importance of addressing the underlying trauma in mental health issues. The speaker, who has a strong belief in the role of trauma, emphasized the significance of going back to the roots of mental health concerns. She expressed her gratitude for the opportunity to share this information for free, but encouraged those interested in continuing education to sign up for CME. She acknowledged the contributions of doctors Tomatsu and Krishnan, and looked forward to a future episode featuring her mentor, Dr. Cummings, who has written a book on psychotic disorders. Overall, the speaker emphasized the importance of ongoing learning and the role of mentorship in the field of mental health. If you're interested in continuing your education, consider signing up for CME or checking out Dr. Cummings' book.

    Recent Episodes from Psychiatry & Psychotherapy Podcast

    Reflective Functioning: The Key to Attachment with Dr. Howard Steele

    Reflective Functioning: The Key to Attachment with Dr. Howard Steele

    In this episode, we discuss “reflective function,” which is a precursor to the concept of mentalization. Reflective function is best understood not as synonymous with mentalization, but as a scale from -1 to 9, based off certain adult attachment interview questions that measure the person’s ability to describe their own and others’ internal states, motivations, and articulate a nuanced and unique understanding of life from 0 to 12 years old. This scale was developed by attachment researchers at the University of London, including Dr. Howard Steele and Dr. Peter Fonagy.

    Bruce Perry on the Healing Power of Human Connection and Resilience in Trauma

    Bruce Perry on the Healing Power of Human Connection and Resilience in Trauma

    In today’s episode, we talk with Dr. Bruce Perry who co-authored, The Boy Who Was Raised As A Dog, Born For Love: Why Empathy is Essential and Endangered, and What Happened to You? Conversations on Trauma, Resilience, and Healing (2021). We are also joined by Megan White Zappitelli, M.D., a child and adolescent psychiatrist, and Maddison Hussey, M.D., a child and adolescent fellow. 

    Early Psychosis: Detection and Treatment

    Early Psychosis: Detection and Treatment

    In this episode, we are joined by a panel of experts to discuss treatment of psychosis. Experiences of psychosis are common. When these experiences lead to interference in achieving life goals and/or distress, individuals can benefit from seeking evidenced-based care. The earlier individuals experiencing psychosis come to treatment, the better the outcomes. We are all allies in connecting these young people to care and services. Recovery is possible—people living with psychosis experiences can lead full, meaningful, and fulfilling lives. 

    Q&A with Dr. Michael Cummings

    Q&A with Dr. Michael Cummings

    In this episode, we welcome back fan favorite Dr. Michael Cummings and ask questions sent in by listeners. Topics include Schizophrenia, Social Media Trends, and the SSRI controversy. We are thrilled to dedicate an episode that allows individuals to ask pointed questions and glean from Dr. Cummings' expertise. 

    What People Want From Therapy with Linda Michaels

    What People Want From Therapy with Linda Michaels

    Therapies of depth, insight, and relationship have been missing from, if not pushed out of, the public conversation on mental health treatment. After decades of attack from multiple fronts, these therapies are misunderstood, undervalued, and overlooked by the general public. In order to address this challenge and change this trajectory, we must start by listening to the public and understand their needs, values, and preferences about therapy. Dr. Linda Michaels and colleagues conducted an extensive research project, leveraging qualitative and quantitative tools and techniques widely used in the corporate world, focused on “listening” to the public and understanding what people want and need from therapy. 

    Linda Michaels, PsyD, MBA, is a clinical psychologist in private practice in Chicago. She is also chair and co-founder of the Psychotherapy Action Network (PsiAN), a non-profit that advocates for quality therapy. 

    Link to blog here.

    5 Factors and Domains of Psychiatric Care

    5 Factors and Domains of Psychiatric Care

    In this Episode, Dr. David Puder, Dr. Adam Borecky, and Joanie Burns discuss the 5-factor approach to holistic, patient-centered psychiatric care. This approach takes into account that each individual who seeks care is unique in their physiological and psychological make-up and that multiple factors influence both physical and mental health (for better or worse). 

    The 5-factor approach to treatment is based on the importance of sensorium and its pivotal role in regulating thoughts, feelings, and overall mental health. Sensorium is a lens to understand how we focus on various things. Sensorium is total brain function, which fluctuates throughout the day and depends on a number of factors, including sleep, stress levels, and more.

    Mentalization Based Therapy (MBT), with Dr. Anthony W. Bateman, MA, FRCPSYCH and Dr. Peter Fonagy, Ph.D., FBA

    Mentalization Based Therapy (MBT), with Dr. Anthony W. Bateman, MA, FRCPSYCH and Dr. Peter Fonagy, Ph.D., FBA

    In this episode, we are joined by Dr. Anthony W. Bateman and Dr. Peter Fonagy to discuss their expertise on Mentalization. 

    Mentalization refers to the capacity to reflect upon and understand one's own state of mind and the states of mind of others.  This involves recognizing and making sense of one's own and others’ emotions, beliefs, needs and desires.  People use this tool consciously and unconsciously to make sense of others and themselves. Often done automatically, a person may form beliefs about the people they interact with, making assumptions about their mental states. These beliefs tend to have a strong influence on the mental state of the person, whether or not they are correct.

     

    Beginning the Treatment with Jonathan Shedler, PhD

    Beginning the Treatment with Jonathan Shedler, PhD

    Dr. Jonathan Shedler is well known for his work on the efficacy of psychodynamic therapy. He has highlighted the importance of the initial phase of therapy in establishing a foundation for successful treatment. Dr. Shedler strongly believes the consultation phase is crucial to developing a working alliance between client and therapist and building a treatment frame and structure. Without this foundation, there is no mutual understanding about the goal or the purpose of treatment, and psychotherapy should not move forward. Join us in this episode as Dr. Shelder discusses how to create a firm starting foundation in clinical practice.

    Adverse Childhood Experiences Part 2: Measurement, Impact on Future Mental Health, Dissociation, and Timing of Trauma

    Adverse Childhood Experiences Part 2: Measurement, Impact on Future Mental Health, Dissociation, and Timing of Trauma

    In this week’s episode of the podcast, we will continue our discussion regarding adverse childhood experiences (ACEs) and their influence on the development of future mental health disorders. The greatest predictive factor of the relationship between ACEs and future mental health disorders has to do with the severity, duration, and number of traumatic events. We’ll explore the Childhood Trauma Questionnaire and the data of how ACEs increase the risk of certain personality disorders and psychiatric conditions.

    Link to blog: 

    https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/episode-204-adverse-childhood-experiences-part-2-measurement-impact-on-future-mental-health-dissociation-and-timing-of-trauma

    Related Episodes

    Opioid Use Disorder with Dr. Cummings

    Opioid Use Disorder with Dr. Cummings

    This week’s episode is on opioid use disorder and is the second in our series on addiction. We are once again joined by Dr. Michael Cummings.  Dr. Puder and Dr. Cummings discuss the history of opioids, the neurobiology of addiction, risk factors for opioid use disorder, and treatment options.

     

    Link to blog here.

    Alcohol Use Disorder with Dr. Cummings

    Alcohol Use Disorder with Dr. Cummings

    In this week’s episode of the podcast, we interview Dr. Michael Cummings, a psychiatrist, researcher, and associate professor at Loma Linda University. This podcast is the first of a series on addiction and the focus of this week’s episode is on alcohol use disorder. In this episode, Dr. Puder and Dr. Cummings dive into the history of alcohol use, vulnerabilities and mechanisms responsible for the development of alcohol use disorder and its related neurobiological circuits, and common pharmacological, psychotherapeutic, and behavioral interventions and treatments for alcohol use disorder.

     

    Link to blog here.

    Psychotic Depression with Dr. Cummings

    Psychotic Depression with Dr. Cummings

    The underreporting of psychotic symptoms by patients in depression is a significant concern, frequently driven by the fear of consequences like hospitalization or the stigma of embarrassment. 

     

    We'll discuss the history, the differential to consider when thinking of psychotic depression, mechanisms, and treatment. Notably, individuals with psychotic depression face a suicide rate double that of their non-psychotic counterparts. A recent cohort study by Paljärvi in 2023 revealed a stark contrast: deaths due to suicide were 2.6% in the psychotic depression cohort, compared to 1% in the non-psychotic group. Alarmingly, most suicides occurred within the first two years following diagnosis. People who suffer from psychotic depression often do not report their psychotic symptoms, leading to inadequate response to normal depression treatments. With 6-25% of individuals with major depressive disorder (MDD) exhibiting psychotic features, it is imperative to understand and address these unique challenges. Join us as we unravel the complexities of this underrecognized aspect of mental health.

    Xylazine, Methamphetamines, Bath Salts, and Spice with Dr. Cummings

    Xylazine, Methamphetamines, Bath Salts, and Spice with Dr. Cummings

    I am thrilled to continue our podcast series on addiction, designed to meet the one-time, 8-hour training requirement introduced by the Consolidated Appropriations Act of 2023. This mandate applies to all practitioners registered with the Drug Enforcement Administration (DEA), and our series primarily focuses on the treatment and management of patients with substance use disorders.

    Link to blog here

    Social Anxiety with Dr. Cummings

    Social Anxiety with Dr. Cummings

    In this episode, Dr. Cummings joins the podcast to discuss and give tips on overcoming social anxiety disorder. Individuals with social anxiety disorder tend to avoid important events and activities, such as classes, meetings, or public speaking. The disorder is essentially the fear of rejection by a group one would like to be part of. This is different from shyness because of the intensity and pervasiveness of the symptoms.

     

    Link to blog here.